2 May 2022
Los Angeles, California, USA
Innovative treatments and diagnostics have the potential to change the lives of millions of patients. But innovation means nothing without access.
For underserved communities that don't have access to high-quality healthcare state-of-the-art therapies, such as early cancer detection and possibly curative cell and gene therapies remain out of reach.
The Access to Medicine Foundation's CEO, Jayasree K. Iyer, will speak at a panel titled “How Can We Ensure Access to Health Innovation for All?” at the 25th Milken Institute Global Conference in Los Angeles, USA. The Milken Institute is a non-profit, nonpartisan think tank determined to increase global prosperity.
Panellists will discuss what policy and payment changes must be made to ensure more people have access to the latest healthcare technologies.
Other speakers on the panel include:
Andrea Ferris, CEO, LUNGevity
Emil Kakkis, CEO, President, and Director, Ultragenyx
AmirAli Talasaz, Co-Founder and Co-CEO, Guardant Health
Jayasree will bring her expertise on the practical steps pharmaceutical companies can take to improve access to their innovative medicines and diagnostics.
Making new products rapidly available to patients who need them requires tactical planning throughout the development phase. The latest Access to Medicine Index, published by the Foundation in January 2021, found an increase in the number of pharmaceutical companies that systematically pair R&D projects with plans for rapidly ensuring people living in low- and middle-income countries rapidly gain access to new products.
Diagnostics is an expanded area of focus for the Foundation. Diagnostics and monitoring devices are an essential element of every health system. However, there is a lack of joined-up strategy for realising the potential of diagnostic testing in lower-income countries. Find out more about how the Foundation intends to trigger critical changes in access to diagnostics here.
Read more about the Milken Institute Global Conference here.